Mexico on Thursday gave emergency authorization to Johnson & Johnson’s coronavirus vaccine. The Mexican government had previously authorized shots from Pfizer and AstraZeneca, as well as Russia’s Sputnik V and China’s Sinovac and CanSino. nyti.ms
@rt.com4 years ago
Hong Kong authorities probe death, hospitalizations that occurred days after people received Sinovac Covid jab
@WSJ4 years ago
China’s Sinovac vaccine showed to be 78% effective against Covid-19 in Brazilian late-stage trials. The efficacy rate is lower than the interim result reported by researchers in Turkey late last month. on.wsj.com
@rt.com3 years ago
North Korea refuses 3mn doses of China’s Sinovac vaccine – UNICEF
@WSJ4 years ago
At least 10 of the 26 doctors in Indonesia who died from Covid-19 this month had received both doses of China’s Sinovac vaccine on.wsj.com
@theguardian.com4 years ago
WHO approves China’s Sinovac Covid vaccine
@aljazeera.com4 years ago
EU regulator begins reviewing China’s Sinovac COVID-19 vaccine
@theguardian.com4 years ago
Coronavirus: two die amid lockdown protests in Gabon; Italian police investigate fake Covid vaccines
@WSJ4 years ago
China’s Sinovac vaccine, which scientists hope can be used to combat Covid-19 in much of the developing world, has shown to be effective in late-stage trials in Brazil, people involved in its development told The Wall Street Journal on.wsj.com
@WSJ3 years ago
North Korea turned down roughly three million doses of China’s Sinovac Covid-19 vaccine, saying they should be sent to harder-hit countries on.wsj.com
@forbes.com4 years ago
China’s Sinovac Vaccine Under Scrutiny As Covid Soars In Highly Vaccinated Countries
@forbes.com4 years ago
World Health Organization Approves China’s Sinovac Coronavirus Vaccine For Emergency Use
@rt.com4 years ago
EU drug regulator launches real-time review of China’s Sinovac coronavirus vaccine
@WSJ4 years ago
China’s drug regulator gave provisional approval to a Covid-19 vaccine developed by Sinovac Biotech, which has faced questions over its efficacy due to a lack of transparency around clinical trial data on.wsj.com
@forbes.com4 years ago
China’s Sinovac To Double Covid-19 Vaccine Output Anticipating Regulatory Approval